Video Experimental Relacionado

Updated: Jan 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Inmunodeficiencia en niños con enfermedad neumocócica invasiva

Ahmed M Almesfer¹, Mohammed M AlSaiary², Fahad M Alharbi³

¹Department of Pediatrics, Pediatric Allergy and Immunology Unit, Maternity and Children Hospital, Dammam, SAU.

|January 9, 2026

Resumen

La enfermedad neumocócica invasiva (ENI) en niños a menudo indica deficiencias inmunitarias subyacentes. La identificación temprana y el manejo adaptado, incluidas las vacunas y la profilaxis, pueden reducir la recurrencia y prevenir resultados graves.

Área de la Ciencia:

Pediatría
Inmunología
Enfermedades Infecciosas

Sus antecedentes:

La enfermedad neumocócica invasiva (ENI) sigue siendo una causa importante de enfermedad y muerte en la infancia, incluso con la vacunación.
La ENI en niños sanos puede indicar inmunodeficiencias previamente desconocidas.
La comprensión de los mecanismos inmunitarios es crucial para la prevención de la ENI.

Objetivo del estudio:

Revisar los mecanismos inmunológicos que predisponen a los niños a la ENI.
Destacar el papel de la ENI como indicador de inmunodeficiencia.
Informar sobre estrategias de manejo individualizadas para la ENI.

Principales métodos:

Revisión narrativa que sintetiza la evidencia de estudios multicéntricos.
Examen de los mecanismos inmunológicos subyacentes a la ENI.
Análisis de defectos inmunitarios comunes (anticuerpos, complemento, señalización innata).

Principales resultados:

Los defectos comunes incluyen deficiencias de anticuerpos/complemento, asplenia congénita y trastornos de la inmunidad innata (MYD88, IRAK4).
Las infecciones de avance ocurren debido a serotipos no vacunales y respuestas inmunitarias alteradas.
La evaluación estructurada posterior a la infección puede identificar defectos inmunitarios de manera temprana.

Conclusiones:

La ENI puede ser un indicador clave de inmunodeficiencia subyacente en niños.
Es esencial un manejo individualizado que optimice las vacunas, la profilaxis y el seguimiento.
La identificación y el manejo tempranos disminuyen la recurrencia de la ENI y mejoran la prevención.

Palabras clave:

deficiencia de anticuerpos niños vía del complemento inmunodeficiencia enfermedad neumocócica invasiva

Más Videos Relacionados

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Videos de Conceptos Relacionados

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: